← All candidates
1 insider filing on record.
1 filing on record.
LEGNLegend Biotech Corp
NasdaqGS · Healthcare · $3.65B
$18.85
-3.79% today
1 insider filing on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 1 sell
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$3.65B
Float
86.7M
45% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
17.2
Price / sales
3.2
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$48.48 avg target
+157.2% vs today · 14 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 3 quarters beat
Q2 '26$0.32 act+$0.04
Q4 '25−$0.16 act−$0.35
Q3 '25−$0.22 act−$0.04
Coverage
LEGN’s New CEO From Novartis Paves Way For Buyout SpeculationStocktwits · 1d agoLegend Names Novartis Executive as CEOThe Wall Street Journal · 1d agoLegend Naming Novartis Executive as CEOThe Wall Street Journal · 1d agoLegend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?Simply Wall St. · 2w ago
The file stays open
1 filing on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice